Epidemiology of gastrointestinal stromal tumors in a defined Canadian Health Region: A population-based study

International Journal of Surgical Pathology

Volumn 16, Issue 3, 2008, Pages 241-250

  Yan, Brian M ^a   Kaplan, Gilaad G ^a   Urbanski, Stefan ^a   Nash, Carla L ^a   Beck, Paul L ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

C kit; CD117; Epidemiology; Gastrointestinal stromal tumor; Population study

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ANTIGENICITY; ARTICLE; CANADA; CANCER INCIDENCE; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; CANADA; COHORT STUDIES; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-KIT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 45749094617     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896907306967     Document Type: Article

References (39)

1. Kitamura Y., Hirota S., Nishida T. Gastrointestinal stromal tumors (GIST): a model for molecule based diagnosis and treatment of solid tumors. Cancer Sci. 2003 ; 94: 315-320.
2. Mazur MT, Clark HB Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol. 1983 ; 7: 507-519.
3. Kindblom LG, Remotti HE, Aldenborg F., Meis-Klindblom JM Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998 ; 152: 1259-1269.
4. Yarden Y., Kuang WJ, Yang-Feng T., et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987 ; 6: 3341-3351.
5. Vliagoftis H., Worobec AS, Metcalfe DD The proto-oncogene c-kit and c-kit ligand in human disease. J Alleg Clin Immunol. 1997 ; 100: 435-440.
6. Huizinga JD, Thuneberg L., Klüppel M., Malysz J., Mikkelsen HB, Bernstein A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature. 1995 ; 373: 347-349.
7. Hirota S., Isozaki K., Moriyama Y., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998 ; 279: 577-580.
8. Dematteo RP, Heinrich MC, El- Rifai W., Demetri G. Clinical management of gastrointestinal stormal tumors: before and after STI-571. Hum Pathol. 2002 ; 33: 466-477.
9. Sarlomo-Rikala M., Kovatich AJ, Barusevicius A., Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998 ; 11: 728-734.
10. Corless CL, Fletcher JA, Heinrich MC Biology of gastrointestinal stromal tumors. J Clin Onc. 2004 ; 22: 3813-3825.
11. Fletcher CDM, Berman JJ, Corless C., et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002 ; 33: 459-465.
12. Miettinen M., Majidi M., Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002 ; 38 (suppl 5). 39S - 51S.
13. Miettinen M., Lasota J. Gastrointestinal stromal tumors- definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001 ; 438: 1-12.
14. Blackstein ME, Dube P., Fletcher JA, et al. Gastrointestinal stromal tumors: etiology, pathology, and clinical management. Can J Gastroenterol. 2004 ; 18 (suppl B). 3B - 8B.
15. Rossi CR, Mocellin S., Mencarelli R., et al. Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer. 2003 ; 107: 171-176.
16. Bucher P., Villiger P., Egger JF, Buhler LH, Morel P. Management of gastrointestinal stromal tumours: from diagnosis to treatment. Swiss Med Wkly. 2004 ; 134: 145-153.
17. Joensuu H., Fletcher C., Dimitrijevic S., Silberman S., Roberts P., Demetri G. Management of malignant gastrointestinal stromal tumors. Lancet Oncol 2002 ; 3: 655-64.
18. DeMatteo RP, Lewis JJ, Leung D., Mudan SS, Woodruff JM, Brennan MF Two hundred gastrointestinal stromal tumors-recurrence patterns and prognostic factors for survival. Ann Surg. 2000 ; 231: 51-58.
19. Tran T., Davila JA, El-Serag HB The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1458 cases from 1992-2000. Am J Gastroenterol. 2005 ; 100: 162-168.
20. Perez EA, Livingstone AS, Franceschi D., et al. Current incidence and outcomes of gastrointestinal mesenchymnal tumors including gastrointestinal stromal tumors. J Am Coll Surg. 2006 ; 202: 623-629.
21. Nilsson B., Bumming P., Meis-Klindblom JM, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in Western Sweden. Cancer. 2005 ; 103: 821-829.
22. Tryggvason G., Gislason HG, Magnusson MK, Jonasson JG Gastrointestinal stromal tumors in Iceland, 1990-2003: the Icelandic GIST study, a population-based incidence and pathological risk stratification study. Int J Cancer. 2005 ; 117: 289-293.
23. Goettsch WG, Bos SD, Breekveldt-Postma N., Casparie M., Herings RMC, Hogendoorn PCW. Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study. Eur J Cancer. 2005 ; 41: 2868-2872.
24. Steigen SE, Eide TJ Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway. APMIS. 2006 ; 114: 192-200.
25. Ahmed I., Welch NT, Parsons SL Gastrointestinal stromal tumours (GIST)-17 years experience from Mid Trent Region (United Kingdom). Eur J Surg Oncol. (2007). doi:10.1016/j.ejso.2007.01.006.
26. Chan KH, Chan CW, Chow WH, et al. Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong. World J Gastroenterol. 2006 ; 12: 2223-2228.
27. Calgary Health Region. http://www.ozcan.ca/chr_map/. Accessed April 30, 2007.
28. Calgary Health Region Website. http://www.calgaryhealthregion.ca//hocr/ influ/demo/demo.htm. Accessed April 30, 2007.
29. Statistics Canada Website. http://www.statcan.ca/english/concepts/health. Accessed April 30, 2007.
30. Connolly EM, Gaffney E., Reynolds JV Gastrointestinal stromal tumors. Br J Surg. 2003 ; 90: 1178-1186.
31. Andersson J., Sihto H., Meis-Kindblom JM, Joensuu H., Nupponen N., Kindblom LG NF-1 associated gastrointestinal stromal tumors have unique clinical, phenotypic and genotypic characteristics. Am J Surg Pathol. 2005 ; 29: 1170-1176.
32. Carney JA, Sheps SG, Go VL, Gordon H. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma, and pulmonary chondroma. N Engl J Med. 1977 ; 296: 1517-1518.
33. Langer C., Gunawan B., Schüler P., Huber W., Füzesi L., Becker H. Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumors. Br J Surg. 2003 ; 90: 332-339.
34. Eisenburg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol. 2003 ; 11: 465-475.
35. Demetri GD, von Mehren M., Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002 ; 347: 472-480.
36. van Oosterom AT, Judson I., Verweij J., et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors: a phase 1 study. Lancet. 2001 ; 358: 1421-1423.
37. De Silva MVC, Reid R. Gastrointestinal stromal tumors (GIST): c-kit mutations, CD117 expression, differential diagnosis, and targeted cancer therapy with imatinib. Pathol Oncol Res. 2003 ; 9: 13-19.
38. Goodman VL, Rock EP, Dagher R., et al. Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. Clin Cancer Res. 2007 ; 13: 1367-1373.
39. Blay JY, Bonvalot S., Casali P., et al. Consensus meeting for the management of gastrointestinal stromal tumors- report of the GIST consensus conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol. 2005 ; 16: 566-578.